METHODS AND MATERS
Electrocardiogram, phonocardiogram and external right carotid arterial pulse wave were simultaneously recorded in the supine position at rest for 10min. The recordings were obtained at a paper speed of 100mm/sec with a 6 channel recorder (Oscillograph Type 100A, San'ei Instru Ltd, Japan and Model CM-601, Fukuda Electro Co, Japan). Phonocardiograms were recorded at the apex and in the second intercostal space at the left parasternal line with a contact microphone (PCG MIC MA-250, Fukuda Electro Co, Japan). External carotid arterial pulse tracings were recorded with a pulse wave microphone (TY-301, Fukuda Electro Co, Japan).
Systolic time intervals were defined according to the method of Weissler et al.3), 4) The time between the onset of Q wave to the onset of the first high frequency vibration of the aortic component of the second heart sound was designated as Q-A2 interval (Fig.1) . The left ventricular ejection time (ET) was measured from the beginning of the carotid upstroke to the trough of the incisura. The externally measured pre-ejection period (PEP) was calculated by subtracting the left ventricular ejection time from the duration of total electromechanical systole (Q-A2). The Simultaneous recording of ECG, PCG, and external carotid arterial pulse wave. Q-A2: total electromechanical systole, ET: left ventricular ejection time, PEP: pre-ejection period (PEP=Q-A2-ET).
ratio of PEP to ET was calculated directly from the uncorrected values. In these calculations, correction was not attempted for heart rate.
All intervals were calculated from the mean of measurements made on 10 consecutive beats, each was read to the nearest 5 msec.
Four patients with Cushing's syndrome (3 females, I male, ranging from 33 to 38 years old), 7 with primary aldosteronism (4 males, 3 females, ranging from 27 to 39 years old), 7 with nephrotic syndrome without corticosteroid treatments (4 males, 3 females, ranging from 18 to 43 years old), 13 with nephrotic syndrome under corticosteroid treatment (5 males, 8 females, ranging from 15 to 45 years old), 7 with collagen disease without corticosteroid (7 females, ranging from 14 to 43 years old), and 11 with collagen disease under the corticosteroid treatment (11 females, ranging from 14 to 43 years old) were examined (Table I) .
Two hundred and seventeen healthy subjects (165 males, 52 females, ranging from 15 to 64 years old) served as the controls.
Four cases which developed overt steroid myopathy, 3 of SLE and I of nephrotic syndrome, were separately analyzed (4 females, ranging from 19 to 36 years old).
Average doses and periods of administration of corticosteroid are given in Table II . (Tables  III  and  IV , Fig.3 ). The early phase of the treatment with large doses of glucocorticoids: Some examples of the course of the PEP/ET ratios in patients with aortitis syndrome, SLE and nephrotic syndrome are shown in Fig.4A to D. The changes in the PEP/ET ratios were variable in the initial phase of the treatment with large doses of glucocorticoid.
DISCUSN
Simultaneous recording of ECG, PCG and external carotid arterial pulse wave has been widely used as a noninvasive and valuable approach to the study of cardiac performance in the clinical field. This technic has such the advantage of allowing repeated evaluations without any harm to the patients. In this study, this approach was applied to examine the effect of steroids on systolic time intervals. There seems to be general agreement that the ratio of pre-ejection period to ventricular ejection time is inversely related to the maximal rate of pressure development of the left ventricle (max dp/dt) , which apparently reflects alteration in the myocardial contractility .5) The ratio of PEP/ET decreases in hyperactive states such as hyperthyroidism , and mental and physical excitement , whereas it increases with impaired myo- Especially in the patients who developed steroid myopathy, the increase in the ratio was quite remarkable. In these patients with steroid myopathy, hypopotassemia was not noted, and the blood pressure was almost identical to the value in Cushing's syndrome and in primary aldosteronism.
Thus, it is likely that not only myopathy of the skeletal muscles but also cardiomyopathy may be induced by the prolonged administration of large doses of glucocorticoids.
The acute pharmacological effect of glucocorticoids on myocardial contractility is said to be enhancing in vivo and in vitro.1), 2) However, as the pharmacological effect of steroid hormones on the PEP/ET ratio is variable as shown in the previous figures (Fig.4A to D) , it can be said that there is no consistent change in the PEP/ET ratio during the early phase of treatment.
Therefore, the apparent impairment of myocardial contractility, seen after prolonged administration of corticosteroids, might have been due to the myocardial changes induced by the hormone.
It is also well known that in Gushing's syndrome organic vascular changes such as wide spread degenerative change and extensive thrombonecrosis of arterioles7) may occur. However, the increased PEP/ET ratio in patients under steroid treatment is restored to normal after discontinuing treatment. Therefore, it is reasonable to think that the cause of increase in PEP/ET ratio in these patients may not be due to irreversible histological changes in coronary artery induced by the chronic administration of glucocorticoids.
In nephrotic syndrome and in collagen disease, the diseases themselves may serve as a main factor impairing myocardial contractility.
Certainly, the ratios were increased already at the beginning of the corticosteroid treatments in these cases, but the ratio increased more with treatments in spite of improvement of the diseases. This increase must be the effect of steroid treatment, and is not due to cardiac involvement of the basic disease .
Although the patients treated with large doses of corticosteroids did not exhibit any clinical evidence of either congestive heart failure or deteriorated cardiac function other than modest sinus tachycardia during follow-up period , the increased PEP/ET ratio may represent the state of impaired myocardial contractility.
It has been widely accepted that the myocardium does not show any remarkable morphological changes in light microscopic finding following steroid treatments.8) However, this conclusion was based on the relatively short-termed observation.
Although a recent electron microscopic and histochemical observation on myocardium under the effect of glucocorticoid revealed some changes such as atrophic myofibrils , structural changes in mitochondria and increase in glycogen granules ,9) it needs further research 
